Navigation Links
DuPont Reports First Quarter Earnings Growth of Over 20 Percent
Date:4/22/2008

10,764 9,945

Accumulated other comprehensive loss (668) (794)

Common stock held in treasury, at cost

(87,041,000 shares at March 31, 2008

and December 31, 2007) (6,727) (6,727)

Total stockholders' equity 12,122 11,136

Total $36,228 $34,131

E. I. du Pont de Nemours and Company

Condensed Consolidated Statements of Cash Flows

(Dollars in millions)

SCHEDULE A (continued)

Three Months Ended

March 31,

2008 2007

Cash used for operating activities $(951) $(240)

Investing activities

Purchases of property, plant and equipment (410) (273)

Investments in affiliates (3) (11)

Other investing activities - net (107) 15

Cash used for investing activities (520) (269)

Financing activities

Dividends paid to stockholders (372) (347)

Net increase in borrowings 1,611 41

Other financing activities - net 23 (119)

Cash provided by (used for) financing

activities 1,262 (425)

Effect of exchange rate changes on cash (2) 3

Decrease in cash and cash equivalents (211) (931)

Cash and cash equivalents at beginning

of period 1,305 1,814 <
'/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
10. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., ... of therapeutic antibodies, today announced the advancement ... program into IND-enabling studies. The Company,s anti-IL-36R ... treatment for generalized pustular psoriasis (GPP), an ... medical need. ANB019 is wholly owned within AnaptysBio,s ...
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, an ... improving cancer surgeries, announced today that it has initiated ... illuminator, AVB-620, in women with primary, non-recurrent breast cancer ... also welcomed the addition of Steven Chen , ... The open label, dose escalation study will enroll up ...
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
(Date:4/16/2015)... Fairleigh Dickinson University ( FDU ... become the Executive Director of the Rothman Institute ... kick-off of the Initiative for Patient Centered Innovation ... under the Rothman Institute of Innovation and Entrepreneurship ... collaboration with FDU’s School of Pharmacy’s Center for ...
Breaking Biology Technology:AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... out of the desert floor at a place called Ash Meadows, ... found nowhere else in the world. A new Brigham Young ... completing a 15,000-year journey, flowing slowly underground from what is now ... there for four decades, and a crack in the Earth,s crust ...
... , June 17 On Friday June 11th , ... for the District of Delaware issued an important pre-trial ruling ... , , , ... defined several key phrases contained in Roquette,s patent claims, thereby dealing a ...
... ... have demonstrated its ability to diminish or eliminate tumor load in melanoma, breast cancer, colon ... ... Inc., a regenerative medicine company developing solutions based on the products of newborn cells grown ...
Cached Biology Technology:SPI Pharma Gains Ground in Roquette Patent Dispute 2Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 2Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation 3
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... fight against the deadly Hendra virus following the development of ... of people who become infected with the virus. ... that administering human monoclonal antibodies after exposure to Nipah virus, ... challenge in a disease model. According to CSIRO,s Dr ...
... SCM Microsystems, Inc. (Nasdaq: SCMM ) (Prime Standard: ... identity and secure exchange, announced today that its stockholders have ... during yesterday,s annual meeting of stockholders. , At ... of SCM,s stockholders cast their votes and a majority followed ...
... that around 2.4 billion years ago, the Earth,s atmosphere ... Called the "Great Oxidation Event" (GOE), the oxygen ... transformation from an oxygen-poor atmosphere to an oxygen-rich one ... the planet. Two questions that remain unresolved in ...
Cached Biology News:Breakthrough in fight against Hendra virus 2SCM Microsystems Announces Results of Annual Meeting 2A new wrinkle in ancient ocean chemistry 2A new wrinkle in ancient ocean chemistry 3
Gap junction protein, beta 2, 26kDa (connexin 26) Antigen: Peptide...
NAP-2 (5C7)...
... The CellSensor CRE-bla HEK 293T cell ... control of the cAMP response element (CRE). ... construct was transduced into HEK 293T cells ... to isolate clones responsive to forskolin stimulation ...
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Biology Products: